GENEVA, Aug. 14 -- DEM BIOPHARMA, INC. filed a patent application (US2025/056954) for “ANTI-SMAGP ANTIBODIES”. With publication no. WO/2026/112624, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: C07K 14/47
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....